Gaudium IVF IPO Fixes Price Band; Promoter’s Rs 15 Lakh Investment Set To Become Rs 75 Crore

Gaudium IVF IPO Pride Band: Gaudium IVF and Women Health has fixed the price band for its initial public offering (IPO) at Rs 75–79 per share. The fertility services provider, which is set to become the first company from the segment to list on stock exchanges in India, is offering 20.89 million shares through the public issue.

The total issue size is Rs 165 crore, which includes 11.39 million fresh equity shares worth Rs 90 crore and an offer-for-sale (OFS) component of 9.49 million shares aggregating to Rs 75 crore.

Meanwhile, Gaudium IVF has fixed the lot size at 189 equity shares per application. At the upper price band, retail investors will need to commit a minimum of Rs 14,931 to bid for one lot.

Gaudium IVF and Women Health, a New Delhi-based in vitro fertilisation (IVF) and women’s healthcare services provider, offers assisted reproductive solutions, and related clinical care and support services.

Promoter’s Rs 15 Lakh Investment Set To Become Rs 75 Crore

Under the offer-for-sale (OFS) component of the Gaudium IVF IPO, promoter Manika Khanna is the only selling shareholder. Khanna will offload 9.49 million shares that she bought earlier at a weighted average price of just Rs 0.16 apiece, according to the red herring prospectus (RHP).

At the upper end of the Rs 75–79 price band, this translates into a return of 492.75 times, or about 49,275 per cent. In absolute terms, the sale is expected to generate a profit of around Rs 74.85 crore on an initial investment of Rs 15.18 lakh. This takes the total realisation to nearly Rs 75 crore.

Gaudium IVF IPO Valuation

Gaudium IVF’s shareholding will increase from 61.39 million shares before the issue to 72.78 million shares after the IPO, following the infusion of fresh issue of equity. At the upper end of the price band, the company is valued at about Rs 575 crore.

Gaudium IVF IPO Dates, Other Details

The Gaudium IVF IPO will open on February 20, 2026, and close on February 24.

The allotment of shares is expected on February 25, and they are scheduled to list on both the BSE and the NSE on February 27.

Sarthi Capital Advisors is the book running lead manager and Bigshare Services is acting as the registrar.

The company has reserved up to 50 per cent of the net issue for Qualified Institutional Buyers (QIBs). It will allocate not less than 35 per cent to retail investors, while Non-Institutional Investors (NIIs) will receive not less than 15 per cent of the offering.

Gaudium IVF IPO Objectives

Gaudium IVF and Women Health plans to utilise the net proceeds from the fresh issue to fund capital expenditure for setting up new IVF centres.

The company will also use a portion of the proceeds to repay or prepay certain outstanding borrowings, and the remaining funds will be allocated for general corporate purposes.

Gaudium IVF Financial Performance

As of the half year ended September 30, 2025 (H1FY26), Gaudium IVF IPO reported total income of Rs 49.75 crore, an Ebitda of Rs 18.95 crore and a profit after tax (PAT) of Rs 12.51 crore.

For the full year FY25, the healthcare company reported a total income of Rs 70.96 crore, up from Rs 48.15 crore in FY24 and Rs 44.26 crore in FY23.

Ebitda for the full year came in at Rs 28.63 crore, up from Rs 19.27 crore in FY24 and Rs 20.07 crore in FY23. PAT stood at Rs 19.13 crore in FY25, up from Rs 10.32 crore in FY24, and Rs 13.53 crore in FY23.

The net worth of Gaudium IVF stood at Rs 58.85 crore as of September 30, 2025, more than doubling from Rs 22.73 crore over the preceding three years. It has a net debt of Rs 22.51 crore and reserves and surplus of Rs 28.16 crore, as of the same date.

Gaudium IVF IPO GMP

Gaudium IVF IPO is quoting a nil grey market premium, as of 10:30 AM on February 17, according to websites that track grey market trades.

It is important to note that GMPs do not reflect actual listing gains and are only an informal indicator of market sentiment in the unlisted space, which can change significantly before the shares list on the exchanges.